1. Home
  2. GWW vs INSM Comparison

GWW vs INSM Comparison

Compare GWW & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W.W. Grainger Inc.

GWW

W.W. Grainger Inc.

HOLD

Current Price

$1,027.82

Market Cap

46.4B

Sector

Industrials

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$176.31

Market Cap

41.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWW
INSM
Founded
1927
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4B
41.2B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
GWW
INSM
Price
$1,027.82
$176.31
Analyst Decision
Hold
Strong Buy
Analyst Count
8
21
Target Price
$1,016.67
$185.84
AVG Volume (30 Days)
291.9K
3.7M
Earning Date
01-30-2026
10-30-2025
Dividend Yield
0.88%
N/A
EPS Growth
N/A
N/A
EPS
35.69
N/A
Revenue
$17,750,000,000.00
$447,022,000.00
Revenue This Year
$5.42
$43.95
Revenue Next Year
$5.06
$130.35
P/E Ratio
$28.70
N/A
Revenue Growth
4.83
30.34
52 Week Low
$893.99
$60.40
52 Week High
$1,139.15
$212.75

Technical Indicators

Market Signals
Indicator
GWW
INSM
Relative Strength Index (RSI) 63.59 39.37
Support Level $1,016.74 $172.65
Resistance Level $1,039.75 $179.44
Average True Range (ATR) 19.18 6.58
MACD 1.12 -2.69
Stochastic Oscillator 83.09 34.58

Price Performance

Historical Comparison
GWW
INSM

About GWW W.W. Grainger Inc.

Founded in 1927, W.W. Grainger originally distributed various motors via a mail-order catalogue. Over the course of the 20th century, the firm expanded into new industrial product categories and launched its first digital catalogue in 1995. Today, the company organizes itself into two segments focused on different customer bases. Its larger segment, high-touch solutions, offers a vast array of maintenance, repair, and operations, or MRO, supplies and bespoke inventory management services to larger businesses. Its smaller segment, endless assortment, operates two online platforms, Zoro and MonotaRO, that offer comprehensive catalogues of MRO supplies to smaller businesses. Grainger has operations throughout the world but primarily generates sales within the US.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: